Neonatal Outcome of Macrosomia
نویسندگان
چکیده
منابع مشابه
Complications and Risk Factors of Neonatal Macrosomia: A Case-Control Study
Background: Macrosomia is defined as the birth weight of greater than or equal to 4,000 grams, which is considered to be a public health issue threatening mothers and neonates. Studies indicate that the prevalence rate of macrosomia is on the rise in developing countries. The present study aimed to evaluate the influential factors in the occurrence of neonatal macrosomia. Methods: This case-co...
متن کاملFetal Macrosomia: Risk Factors, Maternal, and Perinatal Outcome
BACKGROUND Macrosomia is defined as birth-weight over 4,000 g irrespective of gestational age and affects 3-15% of all pregnancies. Aim The present study aimed to determine the relationship between mother's characteristics and macrosomic births and also compare macrosomic and normal newborns regarding the maternal and offspring complications of diabetes during pregnancy. SUBJECTS AND METHODS ...
متن کاملNeonatal anthropometry and neonatal outcome.
Sao Paulo Med J 2003; 121(4):147-148. The use of anthropometric references for the evaluation of intrauterine growth has shown that children whose growth was restricted are more predisposed to metabolic disturbances during the neonatal period, alterations in somatic and neurocognitive development during infancy, increased morbidity and mortality in the first years of life and the appearance of ...
متن کاملFetal macrosomia and neonatal hyperinsulinemic hypoglycemia associated with transplacental transfer of sulfonylurea in a mother with KCNJ11-related neonatal diabetes.
OBJECTIVE Sulfonylureas (SUs) are effective at controlling glycemia in permanent neonatal diabetes mellitus (PNDM) caused by KCNJ11 (Kir6.2) mutations. RESEARCH DESIGN AND METHODS We report the case of a woman with PNDM who continued high doses of glibenclamide (85 mg/day) during her pregnancy. The baby was born preterm, and presented with macrosomia and severe hyperinsulinemic hypoglycemia r...
متن کاملDoes antenatal Betamethasone improve neonatal outcome in late preterm births?
Background and Objective: Preterm birth is a public health problem and late preterm birth (deliveries between 34-36 weeks of gestation) accounts for 75% of all preterm births. Antenatal Betamethasone can reduce the severity of respiratory distress in preterm infants and its effect is accepted in 24-34 weeks of gestation. Our goal was to determine the neonatal outcomes of Betamethasone prescr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Nepal Paediatric Society
سال: 2020
ISSN: 1990-7982,1990-7974
DOI: 10.3126/jnps.v40i2.28917